semaglutide compounding ending FDA Warns on Certain Forms of Compounded Makers of compounded Wegovy, Ozempic

Tell the screening officer you have injectable medication

This dynamic could sustain demand for online research sources even after approval, as it did with both previous GLP-1 agonist launches

In 2024, Metaphore and Novo Nordisk announced a collaboration to create a portfolio of novel research programs to develop transformational medicines, including new therapies for obesity management

The Bottom Line Retatrutide represents an exciting advance in obesity treatment, showing the potential for even greater weight loss than the already impressive tirzepatide

Most events were described as mild to moderate in severity and tended to occur early in treatment, often improving as the body adjusted to the medication